510(k) Report

510(k) · Cleared

Cleared

Nitrile Powder Free Examination Gloves, Tested For Use With Chemotherapy Drugs And Fentanyl Citrate (Dark Blue)

K222449510(k) TraditionalCleared Aug 27, 202212-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Better Care Plastic Technology Co., Ltd. · LZC Medical Glove, Specialty

Cleared on Aug 27, 2022 as substantially equivalent to K192954 (Comfort Rubber Gloves Industries Sdn. Bhd., 2020) after a 12-day review. Its family tree reaches back 2 generations to 2019.

Decided
Aug 27, 2022
Review
12 days
Class
Class I
Product code
LZC
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K183287 (2019). No later device cites it as a predicate yet.

  1. Root · 2 generations backK183287 Powder Free Nitrile Patient Examination Glove, Blue Colored…Kossan International Sdn Bhd · 2019
  2. 1 generation backK192954 Power Free Nitrile Examination Gloves Tested for Use with…Comfort Rubber Gloves Industries Sdn. Bhd. · 2020
  3. This deviceK222449 Nitrile Powder Free Examination Gloves, Tested For Use With…Better Care Plastic Technology Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K183287Powder Free Nitrile Patient Examination Glove, Blue Colored, Non-Sterile…Kossan International Sdn Bhd2019—
−1K192954Power Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs…Comfort Rubber Gloves Industries Sdn. Bhd.2020—
0 (this device)K222449Nitrile Powder Free Examination Gloves, Tested For Use With Chemotherapy Drugs…Better Care Plastic Technology Co., Ltd.2022—
FIG. 1 — Lineage of K222449, 2019–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZC device

  1. #1 K201390 Medline Powder-Free Light Blue Nitrile Exam…score 19.2 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K192954Power Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl
Summary page 4
…formation: Comfort Rubber Gloves Industries Sdn. Bhd. Blue Colored, Power Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (K192954) 4. Device Description: Nitrile Powder Free Examination Gloves, Tested For Use With Chemotherapy Drugs And Fentanyl Citrate (…
Comfort Rubber Gloves Industries Sdn. Bhd.2020—

Also cleared against K192954: 10 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • None of the 2 ancestors has a recall.
  • 10 other devices also cite its predicate K192954.

How does its category compare?

All LZC devices

LZC Medical Glove, Specialty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · LZC

1in 2025

2007: 12008: 32009: 52010: 52012: 42015: 12016: 32017: 62018: 62019: 72020: 32021: 32022: 72025: 12026 (partial year): 1
2007high 7 (2019) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZC

85in 2022

2008: 166 days median2009: 253 days median2010: 68 days median2012: 149 days median2016: 258 days median2017: 121 days median2018: 105 days median2019: 200 days median2020: 167 days median2021: 94 days median2022: 85 days median
2007high 258 (2016) · low 68 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZC

1in 2021

2008: 12011: 42021: 12026 (partial year): 1
2007high 4 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZC

10in 2025

2009: 12011: 12012: 12013: 12014: 32016: 52017: 72018: 62019: 82020: 12021: 22022: 22023: 12024: 162025: 10
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code LZC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008316610
2009525301
201056800
20110—41
2012414901
20130—01
20140—03
20151—00
2016325805
2017612107
2018610506
2019720008
2020316701
202139412
202278502
20230—01
20240—016
20251—010
20261—1—

What is it indicated for?

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs and Fentanyl Citrate using ASTM D6978-05(2019) Chemotherapy Drug Minimum Breakthrough Detection Time (BDT) in Minutes Carmustine 3.3 mg/ml (3,300 ppm) 11.2 Cisplatin 1mg/ml (1,000 ppm) >240 Cyclophosphamide 20mg/ml (20,000 ppm) >240 Dacarbazine 10…

Read the full statement (138 words)

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.

Gloves have been tested for use with chemotherapy drugs and Fentanyl Citrate using ASTM D6978-05(2019)

Chemotherapy Drug Minimum Breakthrough Detection Time (BDT) in Minutes

Carmustine 3.3 mg/ml (3,300 ppm) 11.2

Cisplatin 1mg/ml (1,000 ppm) >240

Cyclophosphamide 20mg/ml (20,000 ppm) >240

Dacarbazine 10 mg/ml (10,000 ppm) >240

Doxorubicin HCL, 2 mg/ml (2,000 ppm) >240

Etoposide, 20 mg/ml (20,000 ppm) >240

Fluorouracil, 50mg/ml (50,000ppm) >240

Methotrexate, 25mg/ml (25,000ppm) >240

Paclitaxel, 6mg/ml (6,000ppm) >240

Thiotepa, 10mg/ml (10,000ppm) 294

Fentanyl Citrate Injection (100 mcg/2ml) >240

Fentanyl Citrate Injection (100 mcg/2ml) >240

Please note that the following drugs have extremely low permeation times:

Carmustine: 11.2 minutes, Thio Tepa: 21.6 minutes

*Warning: Do not use with Carmustine and Thio Tepa.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K222449: Nitrile Powder Free Examination Gloves, Tested For Use With Chemotherapy Drugs And Fentanyl Citrate (Dark Blue).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K222449

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026